Works Cited
- Back to Course Home
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.
1. World Health Organization. Low Back Pain. Available at https://www.who.int/news-room/fact-sheets/detail/low-back-pain. Last accessed July 10, 2025.
2. GBD 2021 Low Back Pain Collaborators. Global, regional, and national burden of low back pain, 1990–2020, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol. 2023;5(6):e316-e329.
3. Buchbinder R, van Tulder M, Öberg B, et al. Low back pain: a call for action. Lancet. 2018;391(10137):2384-2388.
4. Hall AM, Scurrey SR, Pike AE et al. Physician-reported barriers to using evidence-based recommendations for low back pain in clinical practice: a systematic review and synthesis of qualitative studies using the Theoretical Domains Framework. Implementation Sci. 2019;14(49).
5. Mailis A, Taenzer P. Evidence-based guideline for neuropathic pain interventional treatments: spinal cord stimulation, intravenous infusions, epidural injections and nerve blocks. Pain Res Manage. 2012;17(3):150-158.
6. Salmasi V, Lii TR, Humphreys K, Reddy V, Mackey SC. A literature review of the impact of exclusion criteria on generalizability of clinical trial findings to patients with chronic pain. Pain Rep. 2022;7(6):e1050.
7. Katzman JG, Gallagher RM. Pain: the silent public health epidemic. J Prim Care Comm Health. 2024;15:21501319241253547.
8. U.S. Department of Veterans Affairs, U.S. Department of Defense. 2022 VA/DoD Clinical Practice Guideline for the Diagnosis and Treatment of Low Back Pain. Available at https://www.healthquality.va.gov/guidelines/Pain/lbp/VADODLBPCPGFinal508.pdf. Last accessed July 15, 2025.
9. National Center for Health Statistics. Summary Health Statistics: National Health Interview Survey, 2018: Table A-5a. Available at https://ftp.cdc.gov/pub/Health_Statistics/NCHS/NHIS/SHS/2018_SHS_Table_A-5.pdf. Last accessed July 15, 2025.
10. Feldmen DE, Nahin RL. Disability among persons with chronic severe back pain: results from a nationally representative population-based sample. J Pain. 2022;23(12):2144-2154.
11. Dieleman JL, Cao J, Chapin A, et al. US health care spending by payer and health condition, 1996-2016. JAMA. 2020;323(9):863-884.
12. Hartvigsen J, Hancock MJ, Kongsted A, et al. What low back pain is and why we need to pay attention. Lancet. 2018;391(10137):2356-2367.
13. Shokri P, Zahmatyar M, Falah Tafti M, et al. Non-spinal low back pain: global epidemiology, trends, and risk factors. Health Sci Rep. 2023;6(9):e1533.
14. Behrend C, Prasarn M, Coyne E, Horodyski M, Wright J, Rechtine GR. Smoking cessation related to improved patient-reported pain scores following spinal care. J Bone Joint Surg Am. 2012;94(23):2161-2166.
15. Vincent HK, Adams MC, Vincent KR, Hurley RW. Musculoskeletal pain, fear avoidance behaviors, and functional decline in obesity: potential interventions to manage pain and maintain function. Reg Anesth Pain Med. 2013;38(6):481-491.
16. Shiri R, Lallukka T, Karppinen J, Viikari-Juntura E. Obesity as a risk factor for sciatica: a meta-analysis. Am J Epidemiol. 2014;179(8): 929-937.
17. Heuch I, Heuch I, Hagen K, Zwart JA. Body mass index as a risk factor for developing chronic low back pain: a follow-up in the Nord-Trøndelag Health Study. Spine (Phila Pa 1976). 2013;38(2):133-139.
18. Rihn JA, Kurd M, Hilibrand AS, et al. The influence of obesity on the outcome of treatment of lumbar disc herniation: analysis of the Spine Patient Outcomes Research Trial (SPORT). J Bone Joint Surg Am. 2013;95(1):1-8.
19. Karppinen J, Kurunlahti M, Taimela S, Haapea M, Vanharanta H, Tervonen O. Determinants of lumbar artery occlusion among patients with sciatica: a three-year follow-up with magnetic resonance angiography. Eur Spine J. 2005;14(7):664-670.
20. Meredith DS, Huang RC, Nguyen J, Lyman S. Obesity increases the risk of recurrent herniated nucleus pulposus after lumbar microdiscectomy. Spine J. 2010;10(7):575-580.
21. Zhou Y. Principles of pain management. In: Daroff RB, Fenichel GM, Jankovic J, Mazziotta JC (eds). Bradley's Neurology in Clinical Practice. 6th ed. Philadelphia, PA: Saunders; 2012: 783-801.
22. Habib AM, Nagi K, Thillaiappan NB, et al. Vitamin D and its potential interplay with pain signaling pathways. Front Immunol. 2020;11(820)-192
23. Kim TH, Lee BH, Lee HM, et al. Prevalence of vitdeficiency in patients with lumbar spinal stenosis and its relationship with pain.Pain Phyamin D sician. 2013;16(2):165-176.
24. Wickstrom R, Lentz T, Allison S. OSPRO-YF 10-Item Assessment Tool: A Measure of psychosocial risks that influence chronic pain and work disability. Ortho Pract. 2021;33(3):168-192.
25. Rogers AH, Farris SG. A meta-analysis of the associations of elements of the fear-avoidance model of chronic pain with negative affect, depression, anxiety, pain-related disability and pain intensity. Eur J Pain. ٢٠٢٢;٢٦(8):1611-1635.
26. Campbell P, Foster NE, Thomas E, Dunn KM. Prognostic indicators of low back pain in primary care: five-year prospective study.J Pain. 2013;14(8):873-883.
27. Fuss I, Angst F, Lehmann S, Michel BA, Aeschlimann A. Prognostic factors for pain relief and functional improvement in chronic pain after inpatient rehabilitation. Clin J Pain. 2014;30(4):279-285.
28. Russo F, Papalia GF, Diaz Balzani LA, et al. Prognostic factors for return to work in patients affected by chronic low back pain: a systematic review. Musculoskelet Surg. 2024;108(4):403-415.
29. Lou T, Chen Q, Tian M. Comparative efficacy of non-pharmacological interventions on kinesiophobia in patients with chronic non-specific low back pain: a study protocol for a systematic review and network meta-analysis. BMJ Open. 2025;15(4):e096099.
30. Lin IV, O'Sullivan PB, Coffin JA, Mak DB, Toussaint S, Straker LM. Disabling chronic low back pain as an iatrogenic disorder: a qualitative study in Aboriginal Australians. BMJ Open. 2013;3(4):e002654.
31. Mills SEE, Nicolson KP, Smith BH. Chronic pain: a review of its epidemiology and associated factors in population-based studies.Br J Anaesth. 2019;123(2):e273-e283.
32. Seidel B, Singh R, Zaidi M. Post-Laminectomy Pain. Available at https://now.aapmr.org/post-laminectomy-pain. Last accessed July 15, 2025.
33. Itz CJ, Geurts JW, van Kleef M, Nelemans P. Clinical course of non-specific low back pain: a systematic review of prospective cohort studies set in primary care. Eur J Pain. 2013;17(1):5-15.
34. Wallwork SB, Braithwaite FA, O'Keeffe M, et al. The clinical course of acute, subacute and persistent low back pain: a systematic review and meta-analysis. CMAJ. 2024;196(2:E29-E46.
35. Oliveira IS, da Silva T, Pena Costa LO, et al. The long-term prognosis in people with recent onset low back pain from emergency departments: an inception cohort study. J Pain. 2021;22(11):1497-1505.
36. Mescouto K, Olson RE, Hodges PW, Setchell J. A critical review of the biopsychosocial model of low back pain care: time for a new approach? Disab Rehab. 2020;44(13):3270-3284.
37. Cuomo A, Cascella M, Vittori A, et al. Chronic low back pain as a biopsychosocial disease: time to change our point of view. J Anesth Analg Crit Care. 2021;1(7).
38. Mosabbir A. Mechanisms behind the development of chronic low back pain and its neurodegenerative features. Life. 2023;13(1):84.
39. Campbell TS, Johnson JA, Zernicke KA. Gate Control Theory of Pain. In: Encyclopedia of Behavioral Medicine. Cham: Springer International Publishing; 2020. p. 914-916.
40. Allegri M, Montella S, Salici F, et al. Mechanisms of low back pain: a guide for diagnosis and therapy. F1000Res. 2016;8(5):F1000.
41. Yam MF, Loh YC, Tan CS, et al. General pathways of pain sensation and the major neurotransmitters involved in pain regulation.Int J Mol Sci. 2018;19(8):2164.
42. Vardeh D, Mannion RJ, Woolf CJ. Toward a mechanism-based approach to pain diagnosis. J Pain. 2016;17(9):T50-T69.
43. Gorji SM, Samakosh HMN, Watt P, Marchetti PH, Oliveira R. Pain neuroscience education and motor control exercises versus core stability exercises on pain, disability, and balance in women with chronic low back pain. Int J Environ Res Public Health. 2022;19(5):2694.
44. Malfliet A, Kregel J, Coppieters I, et al. Effect of pain neuroscience education combined with cognition-targeted motor control training on chronic spinal pain: a randomized clinical trial. JAMA Neurol. 2018;75(7):808-817.
46. Baliki MN, Petre B, Torbey S, et al. Corticostriatal functional connectivity predicts transition to chronic back pain. Nat Neurosci. 2012;15(8):1117-1119.
47. Hashmi JA, Baliki MN, Huang L, et al. Shape shifting pain: chronification of back pain shifts brain representation from nociceptive to emotional circuits. Brain. 2013;136(Pt 9):2751-2768.
48. Löffler M, Levin SM, Usai K. Corticostriatal circuits in the transition to chronic back pain: the predictive role of reward learning.Cell Rep Med. 2022;3(7):100677.
49. Huang CC, Lee LH, Lin WS, Hsiao TH, Chen IC, Lin CH. The association between bodily pain and cognitive impairment in community-dwelling older adults. J Pers Med. 2022;12(3):350.
50. Seminowicz DA, Wideman TH, Naso L, et al. Effective treatment of chronic low back pain in humans reverses abnormal brain anatomy and function. J Neurosci. 2011;31(20):7540-7550.
51. Norbury TA, MacGregor AJ, Urwin J, Spector TD, McMahon SB. Heritability of responses to painful stimuli in women: a classical twin study. Brain. 2007;130(Pt 11):3041-3049.
52. Kastrati G, Rosén J, Thompson WH, et al. Genetic influence on nociceptive processing in the human brain: a twin study. Cereb Cortex. 2022;32(2):266-274.
53. Jacobsen LM, Schistad EI, Storesund A, et al. The COMT rs4680 Met allele contributes to long-lasting low back pain, sciatica and disability after lumbar disc herniation. Eur J Pain. 2012;16(7):1064-1069.
54. Horjales-Araujo E, Demontis D, Lund EK, et al. Polymorphism in serotonin receptor 3B is associated with pain catastrophizing. PLoS ONE. 2013;8(11):e78889.
55. Horjales-Araujo E, Demontis D, Lund EK, et al. Emotional modulation of muscle pain is associated with polymorphisms in the serotonin transporter gene. Pain. 2013;154(8):1469-1476.
56. Derr M. Lumbar Disc Disorders. Available at https://now.aapmr.org/lumbar-disc-disorders. Last accessed July 15, 2025.
57. Flores S, Hernandez Jr. M, Kalasho B. Discogenic Lumbar Pain Available at https://now.aapmr.org/discogenis-lumbar-pain. Last accessed July 15, 2025.
58. Murphy CA, Fontanez Nieves R, Samarra'e I. Lumbar Radiculopathy. Available at https://now.aapmr.org/lumbar-radiculopathy. Last accessed July 15, 2025.
59. Annaswamy TM, Oberdoerster Z. Lumbar Stenosis. Available at https://now.aapmr.org/lumbar-stenosis. Last accessed July 15, 2025.
60. Liu J, Furman MB. Lumbar Spondylolisthesis. Available at https://now.aapmr.org/lumbar-spondylolisthesis. Last accessed July 15, 2025.
61. Nagpal A, Olusanya A, Bevil A. Lumbar Spondylosis Without Myelopathy/Radiculopathy. Available at https://now.aapmr.org/lumbar-spondylosis-without-myelopathy. Last accessed July 15, 2025.
62. Fitzgerald M. Myofascial Pain. Available at https://now.aapmr.org/myofascial-pain. Last accessed July 15, 2025.
63. Banks D, Kwong E, Martinez M, Portugal S. Facet Mediated Pain. Available at https://now.aapmr.org/facet-mediated-pain. Last accessed July 15, 2025.
64. Lam C, Francio VT, Gustafson K, et al. Myofascial pain—a major player in musculoskeletal pain. Best Pract Res Clin Rheumatol. 2024;38(1):101944.
65. North American Spine Society. Evidence-Based Clinical Guidelines for Multidisciplinary Spine Care: Diagnosis and Treatment of Low Back Pain, 2020. Available at https://www.spine.org/Portals/0/assets/downloads/ResearchClinicalCare/Guidelines/LowBackPain.pdf. Last accessed July 15, 2025.
66. Centre for Effective Practice. Clinically Organized Relevant Exam (CORE) Back Tool. Available at https://cep.health/media/uploaded/CEP_CORE_Back_2016.pdf. Last accessed July 15, 2025.
67. Hall H, Alleyne J, Rampersaud YR. Making sense of low back pain. J Curr Clin Care. 2013;11:12-23.
68. Greenberg JO, Schnell RG. Magnetic resonance imaging of the lumbar spine in asymptomatic adults. J Neuroimaging. 1991;1(1):2-7.
69. Boden SD, Davis DO, Dina TS, Patronas NJ, Wiesel SW. Abnormal magnetic-resonance scans of the lumbar spine in asymptomatic subjects: a prospective investigation. J Bone Joint Surg Am. 1990;72(3):403-408.
70. Jensen MC, Brant-Zawadzki MN, Obuchowski N, Modic MT, Malkasian D, Ross JS. Magnetic resonance imaging of the lumbar spine in people without back pain. N Engl J Med. 1994;331:69-73.
71. Boos N, Rieder R, Schade V, Spratt KF. Semmer N, Aebi M. The diagnostic accuracy of magnetic resonance imaging, work perception, and psychosocial factors in identifying symptomatic disk herniations. Spine (Phila Pa 1976). 1995;20(24):2613-2625.
72. Weishaupt D, Zanetti M, Hodler J, Boos N. MR imaging of the lumbar spine: prevalence of intervertebral disk extrusion and sequestration, nerve root compression, end plate abnormalities, and osteoarthritis of the facet joints in asymptomatic volunteers. Radiology. 1998;209(3):661-666.
73. Wood KB, Garvey TA, Gundry C, Heithoff KB. Magnetic resonance imaging of the thoracic spine: evaluation of asymptomatic individuals. J Bone Joint Surg Am. 1995;77(11):1631-1638.
74. Borenstein DG, O'Mara JW Jr, Boden SD, et al. The value of magnetic resonance imaging of the lumbar spine to predict low-back pain in asymptomatic subjects: a seven-year follow-up study. J Bone Joint Surg Am. 2001;83A(9):1306-1311.
75. Masui T, Yukawa Y, Nakamura S, et al. Natural history of patients with lumbar disc herniation observed by magnetic resonance imaging for minimum 7 years. J Spinal Disord Tech. 2005;18(2):121-126.
76. Smart KM, Blake C, Staines A, Thacker M, Doody C. Mechanisms-based classifications of musculoskeletal pain: part 1 of 3: symptoms and signs of central sensitisation in patients with low back (+/- leg) pain. Man Ther. 2012;17(4):336-344.
77. Smart KM, Blake C, Staines A, Doody C. Mechanisms-based classifications of musculoskeletal pain: part 2 of 3: symptoms and signs of peripheral neuropathic pain in patients with low back (+/- leg) pain. Man Ther. 2012;17(4):345-351.
78. Smart KM, Blake C, Staines A, Doody C. Mechanisms-based classifications of musculoskeletal pain: part 3 of 3: symptoms and signs of nociceptive pain in patients with low back (+/- leg) pain. Man Ther. 2012;17(4):352-357.
79. Vining R, Potocki E, Seidman M, Morgenthal AP. An evidence-based diagnostic classification system for low back pain. J Can Chiropr Assoc. 2013;57(3):189-204.
80. Petersen T, Laslett M, Juhl C. Clinical classification in low back pain: best-evidence diagnostic rules based on systematic reviews. BMC Musculoskelet Disord. 2017;18(1):188.
81. Forster M, Mahn F, Gockel U, et al. Axial low back pain: one painful area, many perceptions and mechanisms. PLoS ONE. 2013;8(7):e68273.
82. Zhou T, Salman D, McGregor AH. Recent clinical practice guidelines for the management of low back pain: a global comparison.BMC Musculoskelet Disord. 2024;25(1):344.
83. Lentz TA, George SZ, Rhon DI. Comparing Start Back Screening Tool and OSPRO Yellow Flag assessment tool subgroups in patients undergoing care for low back pain. J Pain. 2023;24(4):102.
84. Sowdena G, Hill JC, Konstantinou K, et al. Targeted treatment in primary care for low back pain: the treatment system and clinical training programmes used in the IMPaCT Back study (ISRCTN 55174281). Fam Pract. 2012;29(1):50-62.
85. Robinson HS, Dagfinrud H. Reliability and screening ability of the StarT Back screening tool in patients with low back pain in physiotherapy practice, a cohort study. BMC Musculoskelet Disord. 2017;18:232.
86. American Physical Therapy Association. Örebro Musculoskeletal Pain Questionnaire. Available at https://www.apta.org/patient-care/evidence-based-practice-resources/test-measures/orebro-musculoskeletal-pain-questionnaire-ompq. Last accessed July 15, 2025.
87. Agency for Clinical Innovation. Örebro Musculoskeletal Pain Questionnaire. https://aci.health.nsw.gov.au/__data/assets/pdf_file/0004/212908/WorkCover-Orebro-musculoskeletal-pain-questionnaire.pdf. Last accessed July 15, 2025.
89. Wygant DB, Arbisi PA, Bianchini KJ, Umlauf RL. Waddell non-organic signs: new evidence suggests somatic amplification among outpatient chronic pain patients. Spine J. 2017;17(4):505-510.
90. George SZ, Fritz JM, Silfies S, et al. Clinical Practice Guidelines: Interventions for the management of acute and chronic low back pain: revision 2021. J Orthop Sports Phys Ther. 2021;51(11):CPG1-CPG60.
91. Qaseem A, Wilt TJ, McLean RM, et al; for the Clinical Guidelines Committee of the American College of Physicians. Noninvasive treatments for acute, subacute, and chronic low back pain: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2017;166:514-530.
92. Agency for Clinical Innovation. Model of care for the management of low back pain: summary. Available at https://aci.health.nsw.gov.au/__data/assets/pdf_file/0006/807135/ACI-MSK-SIRA-Low-back-pain-MOC-summary.pdf. Last accessed July 15, 2025.
93. Kreiner DS, Hwang SW, Easa JE, et al. An evidence-based clinical guideline for the diagnosis and treatment of lumbar disc herniation with radiculopathy. Spine J. 2014;14(1):180-191.
94. Hegmann KT, Travis, R, Andersson GBJ, et al. ACOEM guidelines: non-invasive and minimally invasive management of low back disorders. JOEM. 2020;62(3):e111-e138.
95. Dalmau-Roig A, Dürsteler C, Ochandorena-Acha M, et al.A multidisciplinary pain management program for patients with chronic low back pain: a randomized, single-blind, controlled, feasibility study.BMC Musculoskelet Disord. 2025;26(59).
96. World Health Organization. WHO Guideline for Non-Surgical Management of Chronic Primary Low Back Pain in Adults in Primary and Community Care Settings. GE: World Health Organization; 2023.
97. Cavalli E, Mammana S, Nicoletti F, Bramanti P, Mazzon E. The neuropathic pain: an overview of the current treatment and future therapeutic approaches. Int J Immunopathol Pharmacol. 2019;33:2058738419838383.
98. Cohen SP, Bhatia A, Buvanendran A, et al. Consensus guidelines on the use of intravenous ketamine infusions for chronic pain from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists. Reg Anesth Pain Med. 2018;43(5):521-546.
99. Schofield P, Dunham M, Martin D, et al. Evidence-based clinical practice guidelines on the management of pain in older people—a summary report. Br J Pain. 2022;16(1):6-13.
100. Nijs J, Malfliet A, Ickmans K, Baert I, Meeus M. Treatment of central sensitization in patients with "unexplained" chronic pain: an update. Expert Opin Pharmacother. 2014;15(12):1-13.
101. Nijs J, Meeus M, Cagnie B, et al. A modern neuroscience approach to chronic spinal pain: combining pain neuroscience education with cognition-targeted motor control training. Phys Ther. 2014;94(5):730-738.
102. Ang DC, Chakr R, Mazzuca S, France CR, Steiner J, Stump T. Cognitive-behavioral therapy attenuates nociceptive responding in patients with fibromyalgia: a pilot study. Arthritis Care Res. 2010;62(5):618-623.
103. de Lange FP, Koers A, Kalkman JS, et al. Increase in prefrontal cortical volume following cognitive behavioural therapy in patients with chronic fatigue syndrome. Brain. 2008;131(Pt 8):2172-2180.
104. Nijs J, van Wilgen CP, Van Oosterwijck J, van Ittersum M, Meeus M. How to explain central sensitization to patients with "unexplained" chronic musculoskeletal pain: practice guidelines. Man Ther. 2011;16(5):413-418.
105. Piano L, Audasso P, Benzi L, et al. Individual education for patients with chronic low back pain: likely a clinically relevant effect for long-term disability compared to noneducational interventions: a systematic review with meta-analysis. J Orthop Sports Phys Ther. 2025;55(5):331-343.
106. Ferreira ML, Ferreira PH, Latimer J, et al. Consumers' perceptions of the smallest worthwhile effect of interventions for non-specific low back pain. J Clin Epidemiol. 2012;65(3):253-261.
107. Oliveira VC, Ferreira PH, Maher CG, et al. Effectiveness of self-management of low back pain: systematic review with meta-analysis. Arthritis Care Res. 2012;64(11):1739-1748.
108. Gao J, Leung HK, Fan J, Wu BWY, Sik HH. The neurophysiology of the intervention strategies of Awareness Training Program on emotion regulation. Front Psychol. 2022;13:891656.
109. Meints SM, Edwards RR, Gilligan C, Schreiber KL. Behavioral, psychological, neurophysiological, and neuroanatomic determinants of pain. J Bone Joint Surg Am. 2020;102(Suppl 1):21-27.
110. Jensen KB, Kosek E, Wicksell R, et al. Cognitive behavioral therapy increases pain-evoked activation of the prefrontal cortex in patients with fibromyalgia. Pain. 2012;153(7):1495-1503.
111. Thieme K, Turk DC, Flor H. Responder criteria for operant and cognitive-behavioral treatment of fibromyalgia syndrome. Arthritis Rheum. 2007;57(5):830-836.
112. Barbara AM, Severn M. Stepped Care Models for Chronic Pain: Technology Review. Ottawa, ON: CADTH Health Technology Review; 2022.
113. Kongsted A, Kent P, Quicke JG. Risk-stratified and stepped models of care for back pain and osteoarthritis: are we heading towards a common model? PAIN Reports. 2020;5(5):e843.
114. University of Pittsburgh. Pittsburgh Sleep Quality Index (PSQI). Available at https://www.sleep.pitt.edu/psqi. Last accessed July 15, 2025.
115. Roland MO, Morris RW. Roland Morris Disability Questionnaire. Available at https://www.rmdq.org. Last accessed July 15, 2025.
116. Sullivan MJL. Pain Catastrophizing Scale. Available at https://www.oregon.gov/oha/HPA/dsi-pmc/PainCareToolbox/Pain%20Catastrophizing%20Scale.pdf. Last accessed July 15, 2025.
117. Tauben D. Chronic pain management: measurement-based step care solutions. IASP. 2012;20(8):1-8.
118. Prins A, Bovin MJ, Kimerling R, et al. Primary Care PTSD Screen for DSM-5 (PC-PTSD-5). Available at https://www.ptsd.va.gov/professional/assessment/screens/pc-ptsd.asp. Last accessed June 15, 2025.
119. Casey MB, Smart KM, Segurado R, Doody C. Multidisciplinary-based rehabilitation (MBR) compared with active physical interventions for pain and disability in adults with chronic pain: a systematic review and metaanalysis. Clin J Pain. 2020;36(11):874-886.
120. Jeffery MM, Butler M, Stark A, Kane RL. Multidisciplinary Pain Programs for Chronic Noncancer Pain. Rockville, MD: Agency for Healthcare Research and Quality; 2011.
121. Schatman ME. Interdisciplinary chronic pain management: perspectives on history, current status, and future viability. In: Fishman SM, Ballantyne J, Rathmell J (eds). Bonica's Management of Pain. 4th ed. Baltimore, MD: Lippincott Williams & Wilkins; 2010:1523-1532.
122. Bontoux L, Dubus V, Roquelaure Y, et al. Return to work of 87 severely impaired low back pain patients two years after a program of intensive functional rehabilitation. Ann Phys Rehabil Med. 2009;52(1):17-29.
123. Petit A, Roche-Leboucher G, Bontoux L, et al. Effectiveness of three treatment strategies on occupational limitations and quality of life for patients with non-specific chronic low back pain: is a multidisciplinary approach the key feature to success: study protocol for a randomized controlled trial. BMC Musculoskelet Disord. 2014;15:131.
124. van Hooff ML, Spruit M, O'Dowd JK, et al. Predictive factors for successful clinical outcome 1 year after an intensive combined physical and psychological programme for chronic low back pain. Eur Spine J. 2014;23(1):102-112.
125. McGregor AH, Probyn K, Cro S, et al. Rehabilitation following surgery for lumbar spinal stenosis. Cochrane Database Syst Rev. 2013;12:CD009644.
126. Gatchel RJ, Mayer TG. Evidence informed management of chronic low back pain with functional restoration. Spine J. 2008;8(1):65-69.
127. Nahin RL, Barnes PM, Stussman BJ. Expenditures on complementary health approaches: United States, 2012. Natl Health Stat Report. 2016;95:1-11.
128. Davis MA, Weeks WB. The concentration of out-of-pocket expenditures on complementary and alternative medicine in the United States. Altern Ther Health Med. 2012;18(5):36-42.
130. Langevin HM. Connective tissue: a body-wide signaling network? Med Hypotheses. 2006;66(6):1074-1077.
131. Langevin HM, Churchill DL, Fox JR, et al. Biomechanical response to acupuncture needling in humans. J Appl Physiol. 2001;91(6):2471-2478.
132. Langevin HM, Churchill DL, Wu J, et al. Evidence of connective tissue involvement in acupuncture. FASEB J. 2002;16(8):872-874.
133. Langevin HM, Fox JR, Koptiuch C, et al. Reduced thoracolumbar fascia shear strain in human chronic low back pain. BMC Musculoskelet Disord. 2011;12:203.
134. Hutchinson AJP, Ball S, Andrews JCH, Jones GG. The effectiveness of acupuncture in treating chronic non-specific low back pain: a systematic review of the literature. J Orthop Surg Res. 2012;7:36-42.
135. McKee MD, Kligler B, Fletcher J, et al. Outcomes of acupuncture for chronic pain in urban primary care. J Am Board Fam Med. 2013;26(6):692-700.
136. Shin J-S, Ha I-H, Lee J, et al. Effects of motion style acupuncture treatment in acute low back pain patients with severe disability: a multicenter, randomized, controlled, comparative effectiveness trial. Pain. 2013;154(7):1030-1037.
138. Sood A, Sood R, Bauer BA, Ebbert JO. Cochrane systematic reviews in acupuncture: methodological diversity in database searching.J Altern Complement Med. 2005;11(4):719-722.
139. Hsu C, Sherman KJ, Eaves ER, et al. New perspectives on patient expectations of treatment outcomes: results from qualitative interviews with patients seeking complementary and alternative medicine treatments for chronic low back pain. BMC Complement Altern Med. 2014;14:276.
140. Centers for Medicare and Medicaid Services. Acupuncture for Chronic Low Back Pain. Available at https://www.cms.gov/medicare-coverage-database/view/ncacal-decision-memo.aspx?proposed=N&NCAId=295. Last accessed July 15, 2025.
141. Holtzman S, Beggs RT. Yoga for chronic low back pain: a meta-analysis of randomized controlled trials. Pain Res Manag. 2013;18(5):267-272.
142. Saper RB, Boah AR, Keosaian J, et al. Comparing once- versus twice-weekly yoga classes for chronic low back pain in predominantly low income minorities: a randomized dosing trial. Evid Based Complement Alternat Med. 2013;2013:658030.
143. Fishman LM, Saltonstall E, Genis S. Understanding and preventing yoga injuries. Int J Yoga Ther. 2009;19:47.
144. Cramer H, Haller H, Lauche R, Dobos G. Mindfulness-based stress reduction for low back pain: a systematic review. BMC Complement Altern Med. 2012;12:162.
145. Ebadi S, Ansari NN, Naghdi S, et al. The effect of continuous ultrasound on chronic non-specific low back pain: a single blind placebo-controlled randomized trial. BMC Musculoskelet Disord. 2012;13:192.
146. Nwuga VC. Ultrasound in treatment of back pain resulting from prolapsed intervertebral disc. Arch Phys Med Rehabil. 1983;64(2):88-89.
147. Ebadi S, Henschke N, Nakhostin Ansari N, et al. Therapeutic ultrasound for chronic low-back pain. Cochrane Database Syst Rev. 2014;(3):CD009169.
148. Ebadi S, Henschke N, Forogh B, et al. Therapeutic ultrasound for chronic low back pain. Cochrane Database Syst Rev. 2020;(7): CD009169.
149. Yousefi-Nooraie R, Schonstein E, Heidari K, et al. Low level laser therapy for nonspecific low-back pain. Cochrane Database Syst Rev. 2008;(2):CD005107.
150. Facci LM, Nowotny JP, Tormem F, Trevisani VF. Effects of transcutaneous electrical nerve stimulation (TENS) and interferential currents (IFC) in patients with nonspecific chronic low back pain: randomized clinical trial. Sao Paulo Med J. 2011;129(4):206-216.
151. Shanti BF, Tan G, Shanti IF. Adjuvant Analgesia for Management of Chronic Pain. Pract Pain Manag. 2012;6(3).
152. Jauregui JJ, Cjerian JJ, Gwam CU, et al. A meta-analysis of transcutaneous electrical nerve stimulation for chronic low back pain. Surg Technol Int. 2016;28:296-302.
153. Wu LC, Weng PW, Chen CH, et al. Literature review and meta-analysis of transcutaneous electrical nerve stimulation in treating chronic back pain. Reg Anesth Pain Med. 2018;43(4):425-433.
154. Kulkarni AD, Smith RB. The use of microcurrent electrical therapy and cranial electrotherapy stimulation in pain control. Clin Prac Alt Med. 2001;2(2):99-102.
155. De Oliveira FN, Dotta L, Sasse A, Teixera MJ, Fonoff ET. Ozone therapy as a treatment for low back pain secondary to herniated disc: a systematic review and meta-analysis of randomized controlled trials. Pain Physician. 2012;15(2):E115-E129.
156. Jeyaraman, M., Jeyaraman, N., Ramasubramanian, S. et al. Ozone therapy in musculoskeletal medicine: a comprehensive review. Eur J Med Res. 2024;29(398)..
157. Costa T, Linhares D, Ribeiro da Silva M, Neves N. Ozone therapy for low back pain: a systematic review. Acta Reumatol Port. 2018;43(3): 172-181.
158. Pappagallo M, Leslie JB, Raffa RB, et al. Evaluation of a novel topical essential oxygen oil for the treatment of pain in acute tendinopathy and sprains. Muscles Ligaments Tendons J. 2011;1(1):25-30.
159. Pergolizzi JV, Pappagallo M, Raffa B, et al. Preliminary observations of a novel topical oil with analgesic properties for treatment of acute and chronic pain syndromes. Pain Pract. 2010;10(3):201-213.
160. Anzolin AP, da Silveira-Kaross NL, Bertol CD. Ozonated oil in wound healing: what has already been proven? Med Gas Res. 2020;10(1):54-59.
161. Staiger C. Comfrey root: from tradition to modern clinical trials. Wien Med Wochenschr. 2013;163(3-4):58-64.
162. Giannetti BM, Staiger C, Bulitta M, Predel HG. Efficacy and safety of a comfrey root extract ointment in the treatment of acute upper or lower back pain: results of a double-blind, randomised, placebo controlled, multicentre trial. Br J Sports Med. 2010;44(9):637-641.
163. Pabst H, Schaefer A, Staiger C, Junker-Samek M, Predel HG. Combination of comfrey root extract plus methyl nicotinate in patients with conditions of acute upper or low back pain: a multicentre randomised controlled trial. Phytother Res. 2013;27(6):811-817.
164. Sherman KJ, Cherkin DC, Ichikawa L, et al. Treatment expectations and preferences as predictors of outcome of acupuncture for chronic back pain. Spine (Phila Pa 1976). 2010;35(15):1471-1477.
165. Behnen EMT. Ask the expert: which NSAIDs are most selective for COX-1 and COX-2? Pract Pain Manag. 2013;13(7):2-5.
166. Canadian Agency for Drugs and Technologies in Health. Non-Steroidal Anti-Inflammatory Drugs for Pain: A Review of Safety. Available at https://www.cadth.ca/sites/default/files/pdf/htis/aug-2013/RC0471%20NSAID%20safety%20final.pdf. Last accessed June 14, 2022.
167. Kuritzky L, Samraj GP. Nonsteroidal anti-inflammatory drugs in the treatment of low back pain. J Pain Res. 2012;5:579-590.
168. Singh G. Recent considerations in nonsteroidal anti-inflammatory drug gastropathy. Am J Med. 1998;105(1B):31S-38S.
169. Straube S, Tramèr MR, Moore RA, Derry S, McQuay HJ. Mortality with upper gastrointestinal bleeding and perforation: effects of time and NSAID use. BMC Gastroenterol. 2009;9:41.
170. Sostres C, Gargallo CJ, Lanas A. Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage. Arthritis Res Ther. 2013;15(Suppl 3):S3.
171. Jarupongprapa S, Ussavasodhi P, Katchamart W. Comparison of gastrointestinal adverse effects between cyclooxygenase-2 inhibitors and non-selective, non-steroidal anti-inflammatory drugs plus proton pump inhibitors: a systematic review and meta-analysis.J Gastroenterol. 2013;48(7):830-838.
172. Castellsague J, Riera-Guardia N, Calingaert B, et al. Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (The SOS Project). Drug Saf. 2012;35(12):1127-1146.
173. Speed C, Wolfarth B. Challenges of pain masking in the management of soft tissue disorders: optimizing patient outcomes with a multi-targeted approach. Curr Med Res Opin. 2014;30(5):953-959.
174. Coxib and Traditional NSAID Trialists' (CNT) Collaboration. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet. 2013;382(9894):769-779.
175. Trelle S, Reichenbach S, Wandel S, et al. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network analysis. BMJ. 2011;342:c7086.
176. McGettigan P, Henry D. Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies. PLoS Med. 2011;8(9):e1001098.
177. NSAIDs and serious cardiovascular disorders: especially COX-2 inhibitors and diclofenac. Prescrire Int. 2016;25(167):14-16.
178. Roelofs PD, Deyo RA, Koes BW, et al. Non-steroidal anti-inflammatory drugs for low back pain. Spine (Phila Pa 1976). 2008;33(16): 1766-1774.
179. Laguerre PJ. Alternatives and adjuncts to opioids for the treatment of chronic pain. N C Med J. 2013;74(3):209-214.
180. UpToDate Lexidrug. Available at https://online.lexi.com. Last accessed July 15, 2025.
181. Williams CM, Maher CG, Latimer J, et al. Efficacy of paracetamol for acute low-back pain: a double-blind, randomised controlled trial. Lancet. 2014;384(9954):1586-1596.
182. Smith HS, Kara SD, Argoff CE. Management of neuropathic pain: current insights and future perspectives. US Neurology. 2012;8(1):57-61.
183. Andrews JS, Wu N, Chen SY, et al. Real-world treatment patterns and opioid use in chronic low back pain patients initiating duloxetine versus standard of care. J Pain Res. 2013;6:825-835.
184. Skljarevski V, Ossanna M, Liu-Seifert H, et al. A double-blind, randomized trial of duloxetine versus placebo in the management of chronic low back pain. Eur J Neurol. 2009;16(9):1041-1048.
185. Skljarevski V, Zhang S, Desaiah D, et al. Duloxetine versus placebo in patients with chronic low back pain: a 12-week, fixed-dose, randomized, double-blind trial. J Pain. 2010;11(12):1282-1290.
186. Skljarevski V, Zhang S, Chappell AS, Walker DJ, Murray I, Backonia M. Maintenance of effect of duloxetine in patients with chronic low back pain: a 41-week uncontrolled, dose-blinded study. Pain Med. 2010;11(5):648-657.
188. Toth C. Pregabalin: latest safety evidence and clinical implications for the management of neuropathic pain. Ther Adv Drug Saf. 2014;5(1):38-56.
189. Shanthanna H, Gilron I, Rajarathinam M, et al. Benefits and safety of gabapentinoids in chronic low back pain: a systematic review and meta-analysis of randomized controlled trials. PLoS Med. 2017;14(8):e1002369.
190. Lyon C, Leggott K, Langner S, Desanto K. Gabapentin for Treatment of Radicular Low Back Pain. 2019;100(5):309-310.
191. Michna E, Cheng WY, Korves C, et al. Systematic literature review and meta-analysis of the efficacy and safety of prescription opioids, including abuse-deterrent formulations, in non-cancer pain management. Pain Med. 2014;15(1):79-92.
192. Jiang J, Pan H, Chen H, et al. Comparative efficacy of pharmacological therapies for low back pain: a Bayesian network analysis. Front Pharmacol. 2022;13:811962.
193. Chung JWY, Zeng Y, Wong TKS. Drug therapy for the treatment of chronic nonspecific low back pain: systematic review and meta-analysis. Pain Physician. 2013;16(6):E685-E704.
194. Chaparro LE, Furlan AD, Deshpande A, Mailis-Gagnon A, Atlas S, Turk DC. Opioids compared to placebo or other treatments for chronic low back pain: an update of the Cochrane review. Spine (Phila Pa 1976). 2014;39(7):556-563.
195. Shaheed CA, Maher CG, Williams KA, Day R, McLachlan AJ. Efficacy, tolerability, and dose-dependent effects of opioid analgesics for low back pain: a systematic review and meta-analysis. JAMA Intern Med. 2016;176(7):958-968.
196. Watson CPN, Watt-Watson J, Chipman M. The long-term safety and efficacy of opioids: a survey of 84 selected patients with intractable chronic noncancer pain. Pain Res Manage. 2010;15(4):213-217.
197. Veiga DR, Monteiro-Soares M. Mendonça L, Sampaio R, Castro-Lopes JM, Azevedo LF. Effectiveness of opioids for chronic noncancer pain; a two-year multicenter, prospective cohort study with propensity score matching. J Pain. 2019;20(6):706-715.
199. Atkinson TJ, Fudin J, Pandula A, Mirza M. Medication pain management in the elderly: unique and underutilized analgesic treatment options. Clin Ther. 2013;35(11):1669-1689.
200. Zorn KE, Fudin J. Treatment of neuropathic pain: the role of unique opioid agents. Practical Pain Manage. 2011;5:26-33, 119.
201. McNulty JP. Can levorphanol be used like methadone for intractable refractory pain? J Palliat Med. 2007;10(2):293-296.
202. Stringer M, Makin M, Miles J, Morley JS. D-morphine, but not L-morphine, has low micromolar affinity for the non-competitive N-methyl-D-aspartate site in rat forebrain: possible clinical implications for the management of neuropathic pain. Neurosci Lett. 2000;295(1-2):21-24.
203. Codd EE, Shank RP, Schupsky JJ, Raffa RB. Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception. J Pharmacol Exp Ther. 1995;274(3):1263-1270.
204. Blake A, Bot G, Li S, Freeman JC, Reisine T. Differential agonist regulation of the human K-opioid receptor. J Neurochem. 1997;68(5):1846-1852.
205. Centers for Disease Control and Prevention. [Archive]. Methadone Linked to 30 Percent of Prescription Painkiller Overdose Deaths. Available at https://www.cdc.gov/media/releases/2012/p0703_methadone.html. Last accessed June 14, 2022.
206. Jones CM, Baldwin GT, Manocchio T, White JO, Mack KA. Trends in methadone distribution for pain treatment, methadone diversion, and overdose deaths—United States, 2002–2014. MMWR. 2016;65:667-671.
207. Dixon R, Crews T, Inturrisi C, Foley K. Levorphanol: pharmacokinetics and steady-state plasma concentrations in patients with pain. Res Commun Chem Pathol Pharmacol. 1983;41(1):3-17.
208. Rowbotham M, Twilling L, Davies P, Reisner L, Taylor K, Mohr D. Oral opioid therapy for chronic peripheral and central neuropathic pain. N Engl J Med. 2003;348(13):1223-1232.
209. Chou R, Cruciani RA, Fiellin DA, et al. Methadone safety: a clinical practice guideline from the American Pain Society and College on Problems of Drug Dependence, in collaboration with the Heart Rhythm Society. J Pain. 2014;15(4):321-337.
210. Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC Clinical Practice Guideline for Prescribing Opioids for Pain —United States, ٢٠٢٢.MMWR Recomm Rep. 2022;71(RR-3):1-95.
211. Kalant H. Marihuana: medicine, addictive substance, or both? A common-sense approach to the place of cannabis in medicine. CMAJ. 2013;4(3):4-9.
212. Fitzcharles MA, Baerwald C, Ablin J, et al. Efficacy, tolerability and safety of cannabinoids in chronic pain associated with rheumatic diseases (fibromyalgia syndrome, back pain, osteoarthritis, rheumatoid arthritis). Schmerz. 2016;30:47.
213. Mathieson S, Kasch R, Maher CG, et al. Combination drug therapy for the management of low back pain and sciatica: systematic review and meta-analysis. J Pain. 2019;20(1):1-15.
214. Romanò CL, Romanò D, Bonora C, Mineo G. Pregabalin, celecoxib, and their combination for treatment of chronic low-back pain.J Orthop Traumatol. 2009;10(4):185-191.
215. Pota V, Maisto M, Pace MC, Aurilio C. Association of buprenorphine TDS and pregabalin in the treatment of low back pain. Eur J Pain. 2007;11(1):83.
216. Khoromi S, Cui L, Nackers L, Max MB. Morphine, nortriptyline and their combination vs. placebo in patients with chronic lumbar root pain. Pain. 2007;130(1-2):66-75.
217. Gilron I, Tu D, Holden RR, Jackson AC, DuMerton-Shore D. Combination of morphine with nortriptyline for neuropathic pain. Pain. 2015;156(8):1440-1448.
219. Zempsky W. Use of topical analgesics in treating neuropathic and musculoskeletal pain. Pain Medicine News. 2013;9:1-4.
220. Haroutiunian S, Drennan DA, Lipman AG. Topical NSAID therapy for musculoskeletal pain. Pain Med. 2010;11(4):535-549.
221. Jorge LL, Feres CC, Teles VE. Topical preparations for pain relief: efficacy and patient adherence. J Pain Res. 2010;4:11-24.
222. Argoff CE. Topical analgesics in the management of acute and chronic pain. Mayo Clin Proc. 2013;88(2):195-205.
224. Derry S, Wiffen PJ, Kalso EA, et al. Topical analgesics for acute and chronic pain in adults—an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2017;5(5):CD008609.
225. U.S. Food and Drug Administration. Flector Patch: Medical Review Part 1. Available at https://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021234s000_MedR_P1.pdf. Last accessed July 15, 2025.
226. McCarberg B, Argoff C. Topical diclofenac epolamine patch 1.3% for the treatment of acute pain caused by soft tissue injury. Int J Clin Pract. 2010;64(11):1546-1553.
227. Hashmi JA, Baliki MN, Huang L, et al. Lidocaine patch (5%) is no more potent than placebo in treating chronic back pain when tested in a randomised double blind placebo controlled brain imaging study. Mol Pain. 2012;8:29.
228. Brau ME, Vogel W, Hempelmann G. Fundamental properties of local anesthetics: half-maximal blocking concentrations for tonic block of NA+ and K+ channels in peripheral nerve. Anesth Analg. 1998;87(4):885-889.
229. Gammaitoni AR, Davis MW. Pharmacokinetics and tolerability of lidocaine patch 5% with extended dosing. Ann Pharmacother. 2002;36(2):236-240.
230. Kanai A, Segawa Y, Okamoto T, Koto M, Okamoto H. The analgesic effect of a metered-dose 8% lidocaine pump spray in posttraumatic peripheral neuropathy: a pilot study. Anesth Analg. 2009;108(3):987-991.
231. Derry S, Wiffen PJ, Moore RA, Quinlan J. Topical lidocaine for neuropathic pain in adults. Cochrane Database Syst Rev. 2014;(7): CD010958.
232. Stein C. Targeting pain and inflammation by peripherally acting opioids. Front Pharmacol. 2013;4:123.
233. Nosek K, Leppert W, Puchała Ł, Łoń K. Efficacy and safety of topical morphine: a narrative review. Pharmaceutics. 2022;14(7):1499.
234. Tennant F, Moll D, DePaulo V. Topical morphine for peripheral pain. Lancet. 1993;342(8878):1047-1048.
235. Lynch ME, Clark AJ, Sawynok J, Sullivan M. Topical 2% amitriptyline and 1% ketamine in neuropathic pain syndromes: a randomized, double-blind, placebo-controlled trial. Anesthesiology. 2005;103(1):140-146.
236. McCleane G. Topical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: a randomized, double-blind, placebo-controlled study. Br J Clin Pharmacol. 2000;49(6):574-579.
237. Quon JA, Fedder PG. Intravenous Lidocaine for Chronic Pain: A Systematic Review. Richmond: WorkSafeBC; 2010.
238. Tremont-Lukats IW, Hutson PR, Backonja M-M. A randomized, double-masked, placebo-controlled pilot trial of extended IV lidocaine infusion for relief of ongoing neuropathic pain. Clin J Pain. 2006;22(3):266-271.
239. Woolf CJ, Wiesenfeldhallin Z. The systemic administration of local-anesthetics produces a selective depression of C-afferent fiber evoked activity in the spinal cord. Pain. 1985;23(4):361-374.
240. Boas RA, Covino BG, Shahnarian A. Analgesic responses to IV lignocaine. Br J Anaesth. 1982;54(5):501-505.
241. Moulin DE, Morley-Forster PK, Pirani Z, Rohfritsch C, Stitt L. Intravenous lidocaine in the management of chronic peripheral neuropathic pain: a randomized-controlled trial. Can J Anaesth. 2019;66(7):820-827.
242. Bredlau AL, Thakur R, Korones DN, Dworkin RH. Ketamine for pain in adults and children with cancer: a systematic review and synthesis of the literature. Pain Med. 2013;14(10):1505-1517.
243. Kapural L, Kapural M, Bensitel T, Sessler DI. Opioid-sparing effect of intravenous outpatient ketamine infusions appears short-lived in chronic-pain patients with high opioid requirements. Pain Physician. 2010;13(4):389-394.
244. Foster L, Clapp L, Erickson M, Jabbari B. Botulinum toxin A and chronic low back pain: a randomized, double-blind study. Neurology. 2001;56(10):1290-1293.
245. Jazayeri SM, Ashraf A, Fini HM, Karimian H, Nasab MV. Efficacy of botulinum toxin type A for treating chronic low back pain. Anesth Pain Med. 2011;1(2):77-80.
246. Busse J W, Genevay S, Agarwal A, et al. Commonly used interventional procedures for non-cancer chronic spine pain: a clinical practice guideline. BMJ. 2025;388:e079970.
247. Pappagallo M, Breuer B, Lin HM, et al. A pilot trial of intravenous pamidronate for chronic low back pain. Pain. 2014;155(1):108-117.
248. Koivisto K, Kyllönen E, Haapea M, et al. Efficacy of zoledronic acid for chronic low back pain associated with Modic changes in magnetic resonance imaging. BMC Musculoskelet Disord. 2014;15:64.
249. Koivisto K, Jarvinen J, Karppinen J, et al. The effect of zoledronic acid on type and volume of Modic changes among patients with low back pain. BMC Musculoskelet Disord. 2017;18(1):274.
250. Tennant F. Hormone Abnormalities in Uncontrolled Chronic Pain Patients. Paper presented at: The American Academy of Pain Management Annual Clinical Meeting; September 18–21, 2014; Phoenix, AZ.
251. Freynhagen R, Baron R, Gockel U, Tolle TR. painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin. 2006;22(10):1911-1920.
252. Varshney V, Osborn J, Chaturvedi R, et al. Advances in the interventional management of neuropathic pain. Ann Translat Med. 2021;9(2).
253. Friedly JL, Comstock BA, Turner JA, et al. Long-term effects of repeated injections of local anesthetic with or without corticosteroid for lumbar spinal stenosis: a randomized trial. Arch Phys Med Rehabil. 2017;98(8):1499-1507.
254. Australian Safety and Efficacy Register of New Interventional Procedures, Surgical. Spinal Surgery for Chronic Low Back Pain: Review of Clinical Evidence and Guidelines. Available at https://database.inahta.org/article/16507. Last accessed July 15, 2025.
255. Cohen SP, Bicket MC, Jamison D, Wilkinson I, Rathmell JP. Epidural steroids: a comprehensive, evidence-based review. Reg Anesth Pain Med. 2013;38(3):175-200.
256. Rabinovitch D, Peliowski A, Furlan A. Influence of lumbar epidural injection volume on pain relief for radicular leg pain and/or low back pain. Spine J. 2009;9(6):509-517.
257. Benoist M, Boulu P, Hayem G. Epidural steroid injections in the management of low-back pain with radiculopathy: an update of their efficacy and safety. Eur Spine J. 2012;21(2):204-213.
258. Armon C, Narayanaswami P, Potrebic S, et al. Use of Epidural Steroid Injections to Treat Radicular Lumbosacral Pain. Available at https://www.aan.com/Guidelines/home/GetGuidelineContent/251. Last accessed July 26, 2025.
259. Manchikanti L, Pampati V, Falco FJ, Hirsch JA. Assessment of the growth of epidural injections in the Medicare population from 2000 to 2011. Pain Physician. 2013;16(4):E349-E364
260. Friedly JL, Comstock BA, Turner JA, et al. A randomized trial of epidural glucocorticoid injections for spinal stenosis. N Engl J Med. 2014;371:11-21.
261. Friedly J, Nishio I, Bishop MJ, Maynard C. The relationship between repeated epidural steroid injections and subsequent opioid use and lumbar surgery. Arch Phys Med Rehabil. 2008;89(6):1011-1015.
262. Amr YM. Effect of addition of epidural ketamine to steroid in lumbar radiculitis: one-year follow-up. Pain Physician. 2011;14(5):475-481.
263. Gupta R, Kaur H, Kaur S, Mahajan L, Kaur T. To compare the analgesic efficacy of two different doses of epidural ketamine in chronic low back pain patients: a randomised double-blind study. Indian J Anaesth. 2020;64(9):768-773.
264. U.S. Food and Drug Administration. FDA Requires Label Changes to Warn of Rare but Serious Neurologic Problems after Epidural Corticosteroid Injections for Pain. Available at https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-requires-label-changes-warn-rare-serious-neurologic-problems-after. Last accessed July 15, 2025.
265. Kumar K, Taylor RS, Jacques L, et al. Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain. 2007;132(1-2):179-188.
266. Kumar K, Taylor RS, Jacques L, et al. The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery. 2008;63(4):762-770.
267. Patel SK, Gozal YM, Saleh MS, et al. Spinal cord stimulation failure: evaluation of factors underlying hardware explantation.J Neurosurg. 2019;32(1):133-138.
268. Shah N, Padalia D. Intrathecal Delivery System. Treasure Island (FL): StatPearls Publishing; 2022.
269. Patel VB, Manchikanti L, Singh V, Schultz DM, Hayek SM, Smith HS. Systematic review of intrathecal infusion systems for long-term management of chronic non-cancer pain. Pain Physician. 2009;12(2):345-60.
270. Watson CPN. Opioids in chronic noncancer pain: more faces from the crowd. Pain Res Manage. 2012;17(4):263-275.
271. Chou R, Loeser JD, Owens DK, et al. Interventional therapies, surgery, and interdisciplinary rehabilitation for low back pain: an evidenced-based clinical practice guideline from the American Pain Society. Spine (Phila Pa 1976). 2009;34(10):1066-1077.
272. Manchikanti L, Datta S, Derby R, Wolfer LR, Benyamin RM, Hirsch JA. A critical review of the American Pain Society clinical practice guidelines for interventional techniques: Part 1: diagnostic interventions. Pain Physician. 2010;13(3):E141-E174.
273. Manchikanti L, Datta S, Gupta S, et al. A critical review of the American Pain Society clinical practice guidelines for interventional techniques: Part 2: therapeutic interventions. Pain Physician. 2010;13(4):E215-E264.
274. Manchikanti L, Benyamin RM, Falco FJ, Caraway DL, Datta S, Hirsch JA. Guidelines warfare over interventional techniques: is there a lack of discourse or straw man? Pain Physician. 2012;15(1):E1-E26.
275. Manchikanti L, Falco FJ, Boswell MV, Hirsch JA. Facts, fallacies, and politics of comparative effectiveness research: part 2: implications for interventional pain management. Pain Physician. 2010;13(1):E55-E79.
276. American Pain Society. Update on the Society. Available at https://painmed.org/american-pain-society. Last accessed June 14, 2022.
277. Taylor ML. The impact of the "business" of pain medicine on patient care. Pain Med. 2011;12(5):763-772.
278. Roth AR, Lazris A, Haskell H, James J. Overuse of interventional procedures for low back pain. Am Fam Physician. 2022;105(6):667-670.
279. Carragee EJ, Deyo RA, Kovacs FM, et al. Clinical research: is the spine field a mine field? Spine (Phila Pa 1976). 2009;34(5):423-430.
280. Aronoff GM. The evolution of pain treatment: is it all about money? Pain Practice. 2011;12(4):326-330.
281. U.S. Census Bureau. Selected Social Characteristics in the United States: American Community Survey. Available at https://data.census.gov/cedsci/table?q=DP02#. Last accessed July 15, 2025.
282. Karliner LS, Napoles-Springer AM, Schillinger D, Bibbins-Domingo K, Pérez-Stable EJ. Identification of limited English proficient patients in clinical care. J Gen Intern Med. 2008;23(10):1555-1560.
283. Flores G. The impact of medical interpreter services on the quality of health care: a systematic review. Med Care Res Rev. 2005;62(3): 255-299.
- Back to Course Home
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.